Lexicon Pharmaceuticals
LXRX
#6208
Rank
A$1.45 B
Marketcap
A$3.28
Share price
-0.43%
Change (1 day)
90.62%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.38 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are A$0.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.27 B-42.43%
2024-12-31A$0.47 B42.47%
2023-12-31A$0.33 B17.94%
2022-12-31A$0.28 B51.19%
2021-12-31A$0.18 B-28.75%
2020-12-31A$0.26 B-55.58%
2019-12-31A$0.59 B47.92%
2018-12-31A$0.40 B-27.87%
2017-12-31A$0.55 B-15.26%
2016-12-31A$0.65 B-26.27%
2015-12-31A$0.89 B55.38%
2014-12-31A$0.57 B87.39%
2013-12-31A$0.30 B-14.09%
2012-12-31A$0.35 B-14.79%
2011-12-31A$0.41 B16.25%
2010-12-31A$0.36 B25.88%
2009-12-31A$0.28 B-22.59%
2008-12-31A$0.37 B-12.25%
2007-12-31A$0.42 B75.01%
2006-12-31A$0.24 B-19.25%
2005-12-31A$0.29 B9.12%
2004-12-31A$0.27 B-28.36%
2003-12-31A$0.38 B6.76%
2002-12-31A$0.35 B-23.84%
2001-12-31A$0.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Thermo Fisher Scientific
TMO
A$162.21 B 42,040.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$9.39 B 2,339.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$58.52 B 15,103.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$1.85 B 382.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.19 B 469.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.66 B 72.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.53 B 39.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$12.30 B 3,095.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$15.09 M-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA